Design and synthesis of novel galactosylated polymers for liposomes as gene drug carriers targeting the hepatic asialoglycoprotein receptor

Journal of Drug Targeting

Volumn 16, Issue 3, 2008, Pages 233-242

  Wang, Si Ling ^a   Yu, Feng Bo ^a   Jiang, Tong Ying ^a   Sun, Chang Shan ^a   Wang, Tianyi ^a   Zhang, Jing Hai ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Galactosylated polymers; Hepatic targeting; Liposomes; Oligodeoxynucleotides (ODNs)

Indexed keywords

1,1' DIOCTADECYL 3,3,3',3' TETRAMETHYLINDOCARBOCYANINE; ASIALOGLYCOPROTEIN RECEPTOR; CHOLESTERYLOXYCARBONYLAMINO ETHYLAMINE ALPHA,BETA POLYASPARTHYDRAZIED; DRUG CARRIER; GALACTOSE; LIGAND; LIPOSOME; MARKER; OLIGODEOXYNUCLEOTIDE; POLYMER; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; DRUG TARGETING; ENCAPSULATION; FROZEN SECTION; GEL FILTRATION; GENE DELIVERY SYSTEM; IN VIVO STUDY; LIVER CELL; LIVER PARENCHYMA; LIVER PERFUSION; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TISSUE DISTRIBUTION; ZETA POTENTIAL;

ANIMALS; ASIALOGLYCOPROTEIN RECEPTOR; GALACTOSE; LIPOSOMES; LIVER; MALE; MICE; OLIGODEOXYRIBONUCLEOTIDES; POLYMERS; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 41549117129     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860801902609     Document Type: Article

References (43)

1. Adida, C., Crotty, PL, McGrath, J., Berrebi, D., Diebold, J. and Altieri, DC (1998) Developmentally regulated expression of the novel cancer anti-apoptosis gene surviving in human and mouse proliferation. Am J Pathol, 152, pp. 43-49.
2. Akhtar, S., Hughes, MD, Khan, A., Bibby, M., Hussain, M., Nawaz, Q., Double, J. and Sayyed, P. (2000) The delivery of antisense therapeutics. Adv Drug Deliv Rev, 44, pp. 3-21.
3. Altieri, DC and Marchisio, PC (1999) Survivin apoptosis: An interloper between cell death and cell proliferation in cancer. Lab Invest, 79, pp. 1327-1333.
4. Ambrosini, G., Adida, C. and Altieri, DC (1997) A novel anti-poptosis gene, survivin, expressed in cancer and lymphoma. Nat Med, 3, pp. 917-921.
5. Bestman-Smith, J., Gourde, P., Désormeaux, A., Tremblay, MJ and Bergeron, MG (2000) Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1. Biochim Biophys Acta, 1468, pp. 161-174.
6. Brigham, KL, Meyrick, B., Christman, B., Magnuson, M., King, G. and Berry, LC (1989) In vivo transfection of murine lungs with a functioning prokaryotic gene using a liposome vehicle. Am J Med Sci, 298:278, p. 18.
7. Bruder, JT and Kovesdi, I. (1997) Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J Virol, 71, pp. 398-404.
8. Byk, G., Dubertret, C., Escriou, V., Frederic, M., Jaslin, G., Rangara, R., Pitard, B., Crouzet, J., Wils, P., Schwartz, B. and Scherman, D. (1998) Synthesis, activity, and structure-activity relationship srudies of novel cationic lipids for DNA transfer. J Med Chem, 41, pp. 224-235.
9. Carter, BZ, Wang, RY, Schober, WD, Milella, M., Chism, D. and Andreeff, M. (2003) Targeting survivin expression induces cell proliferation defect and subsequent cell death involving mitochondrial pathway in myeloid levkemic cell. Cell Cycle, 2, pp. 488-493.
10. Cavallaro, G., Palumbo, FS, Licciardi, M. and Giammona, G. (2005) Novel cationic copolymers of a polyasparthylhydrazide: Synthesis and characterization. Drug Deliv, 12, pp. 377-384.
11. Chen, HR, Chen, TY, Hu, JH and Wang, CC (2005) Nano aggregates of biodegradable amphiphilic poly(hydroxyethyl aspartamide-co-propyl aspartamide) grafted with poly(,-lactide). Colloids Surf A: Physicochem Eng Aspects, 268, pp. 24-29.
12. Connolly, DT, Townsend, RR, Kawaguchi, K., Bell, WR and Lee, YC (1982) Binding and endocytesis of cluster glycosides by rabbit hepatocytes. J Biol Chem, 257, pp. 939-945.
13. Crook, ST (1997) Oligonucleotide analogs might be designed to bind to mRNA. Anticancer Drug Res, 12, pp. 311-313.
14. De Oliveira, MC, Fattal, E., Couvreur, P., Lesieur, P., Bourgaux, C., Ollivon, M. and Dubernet, C. (1998) pH-sensitive liposomes as a carrier for oligonucleotides: A physico-chemical study of the interaction between DOPE and a 15-mer oligonucleotide in quasi-anhydrous samples. Biochim Biophys Acta, 1372, pp. 301-310.
15. Felgner, JH, Kumar, R., Sridhar, CN, Wheeler, CJ, Tsai, YJ, Border, R., Ramsey, P., Martin, M. and Felgner, PL (1994) Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulatilons. J Biol Chem, 269, pp. 2550-2561.
16. Filion, MC and Phillips, NC (1998) Major limitations in the use of cationic liposomes for DNA delivery. Int J Pharm, 162, pp. 159-170.
17. Gao, X. and Huang, L. (1991) A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem Biophys Res Commun, 179, pp. 280-285.
18. Garcia-Chaumont, C., Seksek, O., Grzybowska, J., Borowski, E. and Bolard, J. (2000) Delivery systems for antisense oligonucleotides. Pharmacol Ther, 87, pp. 255-277.
19. Giammona, G., Carlisi, B., Cavallaro, G., Pitarresi, G. and Spampinato, S. (1994) A new water-soluble synthetic polymer, α,β-polyasparthydrazide, as potential plasma expander and drug carrier. J Control Release, 29, pp. 63-72.
20. Giammona, G., Cavallaro, G., Maniscalco, L., Craparo, EF and Pitarresi, G. (2006) Synthesis and characterisation of novel chemical conjugates based on α,β-polyaspartylhydrazide and β-cyclodextrins. Eur Polym J, 42, pp. 2715-2729.
21. Godbey, WT, Wu, KK and Mikos, AG (1999) Poly(ethyenimine) and its role in gene delivery. J Control Release, 60, pp. 149-160.
22. Gupta, PK and Huang, CT (1989) Quantitative evaluation of targeted drug delivery systems. Int J Pharm, 56, pp. 217-226.
23. Haensler, J. and Szoka, FC (1993) Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug Chem, 4, pp. 372-379.
24. He, JF, Cui, GH, Huang, W. and Sun, RA (2001) Preparation and determination of galactosyated bovine serum albumin. J Liaoninng Nat Univ, 24, pp. 389-391.
25. Kawakami, S., Yamashita, F., Nishikawa, M., Takakura, Y. and Hashida, M. (1998) Asialoglycoprotein receptor-mediated gene transfer Using novel galactosylated cationic liposomes. Biochem Biophys Res Commun, 9, pp. 78-83.
26. Kawakami, S., Wong, J., Sato, A., Hattori, Y., Yamashita, F. and Hashida, M. (2000) Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice. Biochim Biophys Acta, 1524, pp. 258-265.
27. Letsinger, RL, Zhang, GR, Sun, DK, Ikeuchi, T. and Sarin, PS (1989) Cholesteryl-conjugated oligonucleotides: Synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture. Proc Natl Acad Sci USA, 86, pp. 6553-6556.
28. Li, LD, Zhang, SW, Lu, FZ, Mu, R., Sun, XD, Huang-Pu, XM, Sun, J., Zhou, YS, Xia, Y., Dai, XD, Rao, KQ, Chen, YD, Sun, AM and Xue, ZF (1997) Research on the death notation and classification characterizations of malignant tumor in China. J Chin Tumor, 19, pp. 323-328.
29. Mahato, RI, Kawabata, K., Nomura, T., Takakura, Y. and Hashida, M. (1995) Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes. J Pharm Sci, 84, pp. 1267-1271.
30. Muruve, DA, Barnes, MJ, Stillman, IE and Libermann, A. (1999) Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum Gene Ther, 10, pp. 965-976.
31. Otake, K., Ennist, DL, Harrod, K. and Trapnell, BC (1998) Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses. Hum Gene Ther, 9, pp. 2207-2222.
32. Pedone, E., Cavallaro, G., Richardson, SC, Duncan, R. and Giammona, G. (2001) α β-Poly(asparthylhydrazide)-glycidyltrimethylammonium chloride copolymers (PAHy-GTA): Novel polymers with potential for DNA delivery. J Control Release, 77, pp. 139-153.
33. Pichon, C., Gonçalves, C. and Midoux, P. (2001) Histidine-rich peptides and polymers for nucleic acids delivery. Adv Drug Deliv Rev, 53, pp. 75-94.
34. Sasaki, M., Hayashi, J., Fujii, M., Koizumi, K., Fujita, H., Kobayashi, M., Kawakubo, Y. and Ito, A. (2001) Neutral liposome-mediated delivery process of fluorescein-modified oligonucleotides in cultured human keratinocytes. J Photochem Photobiol B Biol, 60, pp. 120-128.
35. Singh, M. and Ariatti, M. (2003) Targeted gene delivery into HepG2 cells using complexes containing DNA, cationized asialoorosomucoid and activated cationic liposomes. J Control Release, 92, pp. 383-394.
36. Sun, LM, Yu, YC, Ding, JJ and He, Y. (2005) Determination of cholesterol ointment by colorimetric method. Chin J Pharm, 36, pp. 496-497.
37. Tokunaga, Y., Iwasa, Y., Fujisaki, J., Sawai, S. and Kagayama, A. (1988) Liposomal sustained-realease delivery systems for intravenous injection α. Design of liposome carriers and blood disposition of lipophilic mitomyicin C prodrug-bearing liposomes. Chem Pharm Bull, 36, pp. 3557-3564.
38. Wagner, E., Ogris, M. and Zauner, W. (1998) polylysine-based transfection systems utilizing receptor-mediated delivery. Adv Drug Deliv Rev, 30, pp. 97-113.
39. Wang, SL, Cheng, LH, Yu, FB, Pan, WS and Zhang, JH (2006) Delivery of different length poly(l-lysine)-conjugated ODN to HepG2 cells using N-stearyllactobionamide-modified liposomes and their enhanced cellular biological effects. Int J Pharm, 311, pp. 82-88.
40. Wang, SN, Deng, YH, Wu, HB, Qiu, YK and Chen, DW (2006) Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin. Eur J Pharm Biopharm, 62, pp. 32-38.
41. Willis, M. and Forssen, E. (1998) Ligand-targeted liposomes. Adv Drug Deliv Rev, 29, pp. 249-271.
42. Wu, GY and Wu, CH (1987) Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem, 262, pp. 4429-4432.
43. Yu, FB, Jiang, TY, Zhang, JH, Cheng, LH and Wang, SL (2007) Galactosylated liposomes as oligodeoxynucleotides carrier for hepatocyte-selective targeting. Pharmazie, 62, pp. 528-533.